Is this you? Create Your Porfile
Avatar

Nobutomo Tsuruzoe

Green Cross International

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Nobutomo Tsuruzoe is active.

Explore More

Publication

Featured researches published by Nobutomo Tsuruzoe.

Archive | 1992

5-heteroarylamino-6-oxy-substituted 3(2H)-pyridazinones

Keizo Tanikawa; Akira Saito; Takashi Matsumoto; Ryozo Sakoda; Nobutomo Tsuruzoe; Ken-ichi Shikada

Archive | 1995

Agent for prophylaxis and treatment of thromboxane A2-mediated diseases

Ruriko Ikegawa; Teruaki Imada; Norifumi Nakamura; Keizo Tanikawa; Nobutomo Tsuruzoe

Archive | 1991

5-arylmethylamino-6-oxy-substituted 3(2h)-pyridazinones

Keizo Tanikawa; Akira Saito; Takashi Matsumoto; Ryozo Sakoda; Nobutomo Tsuruzoe; Ken-ichi Shikada

Archive | 1999

Remedial agent for erectile dysfunction

Keizo Tanikawa; Nobutomo Tsuruzoe; Norimasa Shudo; Toru Yamashita; Norihisa Ishiwata; Hideaki Kido; Hajime Ebisu; Kazutaka Hayashi; Yoshiji Kubo; Norifumi Nakamura

Archive | 2010

megakaryopoiesis and thrombopoiesis A novel nonpeptidyl human c-Mpl activator stimulates human

Mamoru Ito; Yasuyuki Ohnishi; Norihisa Ishiwata; Yasuo Ikeda; Nobutomo Tsuruzoe; Takanori Nakamura; Yoshitaka Miyakawa; Atsushi Miyamura; Akiko Yamane; Hidenori Suzuki

Archive | 2009

Vascular intimal hyperplasia inhibitor

Hiroshi Nishiyama; Norimasa Shudo; Nobutomo Tsuruzoe

Archive | 2005

3(2h)-pyridazinone compounds as vascular intimal hyperplasia inhibitor

Hiroshi Nishiyama; Norimasa Shudo; Nobutomo Tsuruzoe

Archive | 1999

Agent therapeutique pour le traitement de la dyserection

Keizo Tanikawa; Nobutomo Tsuruzoe; Norimasa Shudo; Toru Yamashita; Norihisa Ishiwata; Hideaki Kido; Hajime Ebisu; Kazutaka Hayashi; Yoshiji Kubo; Norifumi Nakamura

Archive | 1996

DERIVATIVES OF 3(2H)-PYRIDAZINONE AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND PHARMACEUTICAL COMPOSITION ON THEIR BASE

Kejzo Tanikava; Akira Saito; Takasi Matsumoto; Riozo Sakoda; Nobutomo Tsuruzoe; Ken-Iti Sikada

Archive | 1995

Agent for the prevention and treatment of thromboxane A2 mediated diseases

Ruriko Ikegawa; Teruaki Imada; Norifumi Nakamura; Keizo Tanikawa; Nobutomo Tsuruzoe

Explore More

Collaboration

Dive into the Nobutomo Tsuruzoe's collaboration.

Top Co-Authors
Avatar

Norimasa Shudo

Taisho Pharmaceutical Co.

View shared research outputs
Top Co-Authors
Avatar

Norifumi Nakamura

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors
Avatar

Norihisa Ishiwata

Waseda University

View shared research outputs
Top Co-Authors
Avatar

Ryozo Sakoda

Kagoshima University

View shared research outputs
Top Co-Authors
Avatar

Hideaki Kido

University of Tokyo

View shared research outputs
Top Co-Authors
Avatar

Hiroshi Nishiyama

Hoshi University

View shared research outputs
Top Co-Authors
Avatar

Kazutaka Hayashi

Mitsubishi

View shared research outputs
Top Co-Authors
Avatar

Teruaki Imada

Tokyo Institute of Technology

View shared research outputs
Top Co-Authors
Avatar

Akiko Yamane

Keio University

View shared research outputs
Top Co-Authors
Avatar

Atsushi Miyamura

Waseda University

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge